130 related articles for article (PubMed ID: 37178481)
1. Discovery of pyrimidine-5-carboxamide derivatives as novel salt-inducible kinases (SIKs) inhibitors for inflammatory bowel disease (IBD) treatment.
Cai X; Wang L; Yi Y; Deng D; Shi M; Tang M; Li N; Wei H; Zhang R; Su K; Ye H; Chen L
Eur J Med Chem; 2023 Aug; 256():115469. PubMed ID: 37178481
[TBL] [Abstract][Full Text] [Related]
2. HG-9-91-01 Attenuates Murine Experimental Colitis by Promoting Interleukin-10 Production in Colonic Macrophages Through the SIK/CRTC3 Pathway.
Fu Y; Ma G; Zhang Y; Wang W; Shi T; Zhu J; Zhang J; Huang Z; Chen J
Inflamm Bowel Dis; 2021 Oct; 27(11):1821-1831. PubMed ID: 33988718
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages.
Clark K; MacKenzie KF; Petkevicius K; Kristariyanto Y; Zhang J; Choi HG; Peggie M; Plater L; Pedrioli PG; McIver E; Gray NS; Arthur JS; Cohen P
Proc Natl Acad Sci U S A; 2012 Oct; 109(42):16986-91. PubMed ID: 23033494
[TBL] [Abstract][Full Text] [Related]
4. Small-molecule screening identifies inhibition of salt-inducible kinases as a therapeutic strategy to enhance immunoregulatory functions of dendritic cells.
Sundberg TB; Choi HG; Song JH; Russell CN; Hussain MM; Graham DB; Khor B; Gagnon J; O'Connell DJ; Narayan K; Dančík V; Perez JR; Reinecker HC; Gray NS; Schreiber SL; Xavier RJ; Shamji AF
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12468-73. PubMed ID: 25114223
[TBL] [Abstract][Full Text] [Related]
5. The clinically approved drugs dasatinib and bosutinib induce anti-inflammatory macrophages by inhibiting the salt-inducible kinases.
Ozanne J; Prescott AR; Clark K
Biochem J; 2015 Jan; 465(2):271-9. PubMed ID: 25351958
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of SIK2 and SIK3 during differentiation enhances the anti-inflammatory phenotype of macrophages.
Darling NJ; Toth R; Arthur JS; Clark K
Biochem J; 2017 Feb; 474(4):521-537. PubMed ID: 27920213
[TBL] [Abstract][Full Text] [Related]
7. The pentacyclic triterpene Lupeol switches M1 macrophages to M2 and ameliorates experimental inflammatory bowel disease.
Zhu Y; Li X; Chen J; Chen T; Shi Z; Lei M; Zhang Y; Bai P; Li Y; Fei X
Int Immunopharmacol; 2016 Jan; 30():74-84. PubMed ID: 26655877
[TBL] [Abstract][Full Text] [Related]
8. Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312.
Temal-Laib T; Peixoto C; Desroy N; De Lemos E; Bonnaterre F; Bienvenu N; Picolet O; Sartori E; Bucher D; López-Ramos M; Roca Magadán C; Laenen W; Flower T; Mollat P; Bugaud O; Touitou R; Pereira Fernandes A; Lavazais S; Monjardet A; Borgonovi M; Gosmini R; Brys R; Amantini D; De Vos S; Andrews M
J Med Chem; 2024 Jan; 67(1):380-401. PubMed ID: 38147525
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of negative modulation of FSH signaling by salt-inducible kinases in rat granulosa cells.
Armouti M; Rodriguez-Esquivel M; Stocco C
Front Endocrinol (Lausanne); 2022; 13():1026358. PubMed ID: 36246922
[TBL] [Abstract][Full Text] [Related]
10. SIK inhibition in human myeloid cells modulates TLR and IL-1R signaling and induces an anti-inflammatory phenotype.
Lombardi MS; Gilliéron C; Dietrich D; Gabay C
J Leukoc Biol; 2016 May; 99(5):711-21. PubMed ID: 26590148
[TBL] [Abstract][Full Text] [Related]
11. Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation.
Babbe H; Sundberg TB; Tichenor M; Seierstad M; Bacani G; Berstler J; Chai W; Chang L; Chung M; Coe K; Collins B; Finley M; Guletsky A; Lemke CT; Mak PA; Mathur A; Mercado-Marin EV; Metkar S; Raymond DD; Rives ML; Rizzolio M; Shaffer PL; Smith R; Smith J; Steele R; Steffens H; Suarez J; Tian G; Majewski N; Volak LP; Wei J; Desai PT; Ong LL; Koudriakova T; Goldberg SD; Hirst G; Kaushik VK; Ort T; Seth N; Graham DB; Plevy S; Venable JD; Xavier RJ; Towne JE
Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2307086120. PubMed ID: 38147543
[TBL] [Abstract][Full Text] [Related]
12. Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases.
Peixoto C; Joncour A; Temal-Laib T; Tirera A; Dos Santos A; Jary H; Bucher D; Laenen W; Pereira Fernandes A; Lavazais S; Delachaume C; Merciris D; Saccomani C; Drennan M; López-Ramos M; Wakselman E; Dupont S; Borgonovi M; Roca Magadan C; Monjardet A; Brys R; De Vos S; Andrews M; Jimenez JM; Amantini D; Desroy N
J Med Chem; 2024 Apr; 67(7):5233-5258. PubMed ID: 38552030
[TBL] [Abstract][Full Text] [Related]
13. Nuts and bolts of the salt-inducible kinases (SIKs).
Darling NJ; Cohen P
Biochem J; 2021 Apr; 478(7):1377-1397. PubMed ID: 33861845
[TBL] [Abstract][Full Text] [Related]
14. LKB1 controls inflammatory potential through CRTC2-dependent histone acetylation.
Compton SE; Kitchen-Goosen SM; DeCamp LM; Lau KH; Mabvakure B; Vos M; Williams KS; Wong KK; Shi X; Rothbart SB; Krawczyk CM; Jones RG
Mol Cell; 2023 Jun; 83(11):1872-1886.e5. PubMed ID: 37172591
[TBL] [Abstract][Full Text] [Related]
15. Salt-inducible kinases: new players in pulmonary arterial hypertension?
António T; Soares-da-Silva P; Pires NM; Gomes P
Trends Pharmacol Sci; 2022 Oct; 43(10):806-819. PubMed ID: 35851157
[TBL] [Abstract][Full Text] [Related]
16.
Xu YW; Xing RX; Zhang WH; Li L; Wu Y; Hu J; Wang C; Luo QL; Shen JL; Chen X
World J Gastroenterol; 2019 Dec; 25(45):6634-6652. PubMed ID: 31832003
[TBL] [Abstract][Full Text] [Related]
17. Salt-inducible kinases inhibitor HG-9-91-01 targets RIPK3 kinase activity to alleviate necroptosis-mediated inflammatory injury.
Huang D; Chen P; Huang G; Sun H; Luo X; He C; Chen F; Wang Y; Zeng C; Su L; Zeng X; Lu J; Li S; Huang D; Gao H; Cao M
Cell Death Dis; 2022 Feb; 13(2):188. PubMed ID: 35217652
[TBL] [Abstract][Full Text] [Related]
18. Discovery and Anti-Inflammatory Activity Evaluation of a Novel CDK8 Inhibitor through Upregulation of IL-10 for the Treatment of Inflammatory Bowel Disease
Yan Y; Xing C; Xiao Y; Shen X; Zhang Z; He C; Shi JB; Liu M; Liu X
J Med Chem; 2022 May; 65(10):7334-7362. PubMed ID: 35536548
[TBL] [Abstract][Full Text] [Related]
19. The Salt-Inducible Kinases: Emerging Metabolic Regulators.
Sakamoto K; Bultot L; Göransson O
Trends Endocrinol Metab; 2018 Dec; 29(12):827-840. PubMed ID: 30385008
[TBL] [Abstract][Full Text] [Related]
20. Mitogenic Signals Stimulate the CREB Coactivator CRTC3 through PP2A Recruitment.
Sonntag T; Ostojić J; Vaughan JM; Moresco JJ; Yoon YS; Yates JR; Montminy M
iScience; 2019 Jan; 11():134-145. PubMed ID: 30611118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
